GRIN2B and Alzheimer disease: Since the GluN2B subunit is present [9] in extrasynaptic NMDA receptors and Tau overexpression has also been implicated in the overactivation of extrasynaptic NMDA receptors [63], it could be considered a potential target for the treatment of neurodegenerative disorders related to aging such as AD.